ADVI Health is thrilled to welcome Juli Denny as its new Chief Growth Officer. In this pivotal executive role, Juli will lead the Business Development and Marketing teams, driving global commercial strategy and an integrated approach with ADVI’s expert advisory services to focus on company growth.

Juli joins ADVI with over 25 years of proven success as an executive leader in the medical device, pharmaceutical, and broader life sciences industries. Her deep experience includes building, scaling, and leading high-performing sales, marketing, and business development teams.

Before joining ADVI Health, Juli served as the Chief Growth Officer at Network Partners Group (NPG), where she developed and led the full commercial team, creating the company’s first corporate sales strategy. Her career highlights include leading business development teams to drive global revenue for six consecutive years at RQM+, serving on the executive team for multiple companies, and leading the integration of newly acquired companies for all commercial divisions following two private equity transactions. Juli has also held senior executive roles as President & CEO of Boost Sales Advisors LLC, Chief Commercial Officer at Celegence, and Vice President of Commercialization at RQM+.

“Juli is a seasoned executive with an unparalleled track record of driving monumental and sustainable growth,” said Marc Samuels, CEO of ADVI. “Her experience will be invaluable as ADVI enters its next phase of expansion, partnering with life sciences and healthcare innovators worldwide. Juli understands that the key to our growth lies in creating a powerful, seamless alliance between our outstanding business development and consulting teams to maximize value delivery for our clients.”

Juli is known for her collaborative leadership style. She focuses on building strong relationships and fostering a shared vision and process between everyone she works with.

“I am incredibly excited to join the ADVI team, especially at a time of such growth,” said Juli. “ADVI’s commitment to providing unmatched market access, policy, strategic analytics, and data solutions to companies at the forefront of innovation is a critical mission. I look forward to working with each of the teams with ADVI to better position them and support their clients by creating a more integrated process across ADVI, amplifying what is already working and finding ways to achieve even more success together.”

Juli Denny’s appointment reinforces ADVI’s dedication to excellence and paves the way for ongoing success in delivering expert advice, informed by data, and guided by a clear vision of the complex intersection of life sciences and healthcare innovation, economics, policy, and patient impact.